Novartis Presents Promising Oncology and Hematology Data at ASCO and EHA

Novartis announced the presentation of data from 60 abstracts at the 2025 ASCO Annual Meeting and EHA 2025 Congress. The data showcases the momentum ...
Home/KnloSights/Clinical Trial Updates/Novartis Presents Promising Oncology and Hematology Data at ASCO and EHA